Mifamurtide
Top View
- MEPACT® Prescribing Information
- (INN) for Biological and Biotechnological Substances
- Access to Cancer Medicines in Europe: an Analysis of Existing Challenges and Countries’ Responses
- Estonian Statistics on Medicines 2014
- Advances on the Formulation of Proteins Using Nanotechnologies
- Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection
- List Item Minutes of the PRAC Meeting 6-9 October 2014
- Mifamurtide and TAM-Like Macrophages: Effect on Proliferation, Migration and Differentiation of Osteosarcoma Cells
- NICE Tas RFL Formulary Sept 2016
- Future Directions in the Treatment of Osteosarcoma
- Microencapsulated Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceutical Agents
- Vaccine Efficacy Against Primary and Metastatic Cancer with in Vitro-Generated CD103+ Conventional Dendritic Cells
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Who Drug Information
- Repurposing Drugs for COVID-19 Based on Transcriptional Response of Host Cells to SARS-Cov-2
- Nanotechnology As a Platform for the Development of Injectable Parenteral Formulations: a Comprehensive Review of the Know-Hows and State of the Art
- Pharmaabkommen A1 E
- ABSTRACT BOOK 18Th Congress of the EAHP, 13-15 March 2013, Paris, France March 2013